Related Experiment Video

Updated: Jul 18, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Hypertensive crisis, hepatitis B virus and polyarteritis nodosa in a child

Alexandre Belot1, Bruno Ranchin, Isabelle Canterino

  • 1Néphrologie Pédiatrique, Hôpital Edouard Herriot, Lyon, France.

Pediatric Nephrology (Berlin, Germany)
|November 16, 2006
PubMed

Insights

Hepatitis B virus-associated polyarteritis nodosa (PAN) in a child was successfully treated with a combination of prednisone, plasma exchange, and interferon-alpha. Long-term follow-up showed no signs of disease, normal blood pressure, and preserved renal function.

Area of Science:

  • Pediatric Rheumatology
  • Hepatology
  • Infectious Diseases

Background:

  • Polyarteritis nodosa (PAN) is a rare systemic vasculitis that can affect medium-sized arteries.
  • Hepatitis B virus (HBV) infection is a known cause of PAN, particularly in endemic areas.
  • Early diagnosis and treatment are crucial for managing PAN and preventing organ damage.

Observation:

  • A 4-year-old boy presented with severe arterial hypertension, leading to the investigation of potential underlying conditions.
  • Conventional renal arteriography confirmed the diagnosis of polyarteritis nodosa.
  • The patient had a confirmed Hepatitis B virus infection.

Findings:

  • The child received intensive sequential therapy including short-term prednisone, plasma exchange, and interferon-alpha-2b.
  • Following treatment, the patient achieved remission of PAN.
  • Nine years post-treatment, the patient remained disease-free with normal blood pressure and normal renal function without ongoing therapy.

Implications:

  • This case highlights the effectiveness of a multi-modal treatment approach for HBV-related PAN in pediatric patients.
  • Aggressive treatment can lead to long-term remission and favorable outcomes, including preserved organ function.
  • This therapeutic strategy may serve as a valuable model for managing similar complex pediatric vasculitis cases.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...